SCHEDULE: Squadron Master Fund Boosts Stake in Relmada
Beneficial Ownership Report
Squadron Master Fund LP and affiliates report increased passive beneficial ownership in Relmada Therapeutics, Inc., reaching up to 9.9% of common stock.
Summary
- Squadron Master Fund LP, Squadron Capital Management LLC, and William Blank have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in RELMADA THERAPEUTICS, INC.
- Squadron Master Fund LP beneficially owns 2,914,495 shares, representing 8.8% of the common stock.
- Squadron Capital Management LLC and William Blank each beneficially own 3,298,500 shares, representing 9.9% of the common stock.
- The ownership percentages are based on 33,191,622 shares of common stock outstanding as of May 7, 2025, as reported by the Issuer in its Form 10-Q filed on May 12, 2025.
- Squadron Capital Management LLC serves as an investment adviser to private funds, including Squadron Master Fund LP.
- William Blank, as a Partner of Squadron Capital Management, LLC, has the power to exercise investment and voting discretion over the shares held by the Funds.
- The reporting persons expressly disclaim beneficial ownership over the reported securities, stating the filing is not an admission of beneficial ownership.
- The securities were not acquired or held for the purpose of changing or influencing control of the issuer, nor in connection with a transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.
Sentiment
Score: 5
Explanation: A Schedule 13G filing is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the company's performance or outlook. The sentiment is neutral as it simply reports a change in ownership stake.
Positives
- Increased stake by institutional investors may signal confidence in the company's long-term prospects.
- The filing indicates a passive investment intent, which typically means the investor is not seeking to disrupt current management or operations.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Increased institutional ownership could be viewed positively, potentially indicating investor confidence or stability.
- Management: The passive nature of the investment suggests no immediate intent to influence control, which could be seen as stable for current management.
Key Dates
| Date | Description |
|---|---|
| 2025-05-07 | Date as of which 33,191,622 shares of common stock were outstanding, as reported by the Issuer in its Form 10-Q. |
| 2025-05-12 | Date the Issuer filed its Form 10-Q with the SEC, reporting outstanding shares. |
| 2025-06-30 | Date of event which requires filing of this statement. |
| 2025-08-14 | Date of filing and signature by reporting persons. |
Keywords
RELMADA THERAPEUTICS, RLMD, Squadron Master Fund, Squadron Capital Management, William Blank, beneficial ownership, Schedule 13G, institutional investment, passive stake, common stock, investment adviser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.